Silibinin, dexamethasone, and doxycycline as potential therapeutic agents for treating vesicant-inflicted ocular injuries

Toxicology and Applied Pharmacology

Volumn 264, Issue 1, 2012, Pages 23-31

  Tewari Singh, Neera ^a   Jain, Anil K ^a   Inturi, Swetha ^a   Ammar, David A ^b   Agarwal, Chapla ^a   Tyagi, Puneet ^a   Kompella, Uday B ^a   Enzenauer, Robert W ^b   Petrash, J Mark ^b   Agarwal, Rajesh ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Dexamethasone; Doxycycline; Microbullae; Nitrogen mustard; Rabbit eye corneal culture; Silibinin

Indexed keywords

BIOLOGICAL MARKER; CHLORMETHINE; CYCLOOXYGENASE 2; DEXAMETHASONE; DOXYCYCLINE; FLAVANONE; GELATINASE B; MUSTARD GAS; SILIBININ; VASCULOTROPIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CORNEA; CORNEA EPITHELIUM; CORNEA ULCER; EYE INJURY; NONHUMAN; REACTION TIME; SKIN INJURY; THICKNESS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; CHEMICAL WARFARE AGENTS; CORNEAL DISEASES; CYCLOOXYGENASE 2; DEXAMETHASONE; DOXYCYCLINE; DRUG THERAPY, COMBINATION; EPITHELIUM, CORNEAL; IRRITANTS; MECHLORETHAMINE; MUSTARD GAS; RABBITS; SILYMARIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ORYCTOLAGUS CUNICULUS;

EID: 84865974634     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.07.014     Document Type: Article

References (67)

1. Amir A., Turetz J., Chapman S., Fishbeine E., Meshulam J., Sahar R., Liani H., Gilat E., Frishman G., Kadar T. Beneficial effects of topical anti-inflammatory drugs against sulfur mustard-induced ocular lesions in rabbits. J. Appl. Toxicol. 2000, 20(Suppl. 1):S109-S114.
2. Banin E., Morad Y., Berenshtein E., Obolensky A., Yahalom C., Goldich J., Adibelli F.M., Zuniga G., DeAnda M., Pe'er J., Chevion M. Injury induced by chemical warfare agents: characterization and treatment of ocular tissues exposed to nitrogen mustard. Investig. Ophthalmol. Vis. Sci. 2003, 44:2966-2972.
3. Bary A.R., Tucker I.G., Davies N.M. Considerations in the use of hydroxypropyl-beta-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone. Eur. J. Pharm. Biopharm. 2000, 50:237-244.
4. Black A.T., Hayden P.J., Casillas R.P., Heck D.E., Gerecke D.R., Sinko P.J., Laskin D.L., Laskin J.D. Expression of proliferative and inflammatory markers in a full-thickness human skin equivalent following exposure to the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfide. Toxicol. Appl. Pharmacol. 2010, 249:178-187.
5. Brimfield A.A., Mancebo A.M., Mason R.P., Jiang J.J., Siraki A.G., Novak M.J. Free radical production from the interaction of 2-chloroethyl vesicants (mustard gas) with pyridine nucleotide-driven flavoprotein electron transport systems. Toxicol. Appl. Pharmacol. 2009, 234:128-134.
6. Chang J.H., Gabison E.E., Kato T., Azar D.T. Corneal neovascularization. Curr. Opin. Ophthalmol. 2001, 12:242-249.
7. Cheung C.W., Gibbons N., Johnson D.W., Nicol D.L. Silibinin-a promising new treatment for cancer. Anti cancer Agents Med. Chem. 2010, 10:186-195.
8. Chung J.H., Paek S.M., Choi J.J., Park Y.K., Lee J.S., Kim W.K. Effect of topically applied 0.1% dexamethasone on endothelial healing and aqueous composition during the repair process of rabbit corneal alkali wounds. Curr. Eye Res. 1999, 18:110-116.
9. Cox C.A., Amaral J., Salloum R., Guedez L., Reid T.W., Jaworski C., John-Aryankalayil M., Freedman K.A., Campos M.M., Martinez A., Becerra S.P., Carper D.A. Doxycycline's effect on ocular angiogenesis: an in vivo analysis. Ophthalmology 2010, 117:1782-1791.
10. Deep G., Agarwal R. Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer. Cancer Metastasis Rev. 2010, 29:447-463.
11. Flaig T.W., Gustafson D.L., Su L.J., Zirrolli J.A., Crighton F., Harrison G.S., Pierson A.S., Agarwal R., Glode L.M. A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. Invest. New Drugs 2007, 25:139-146.
12. Foreman D.M., Pancholi S., Jarvis-Evans J., McLeod D., Boulton M.E. A simple organ culture model for assessing the effects of growth factors on corneal re-epithelialization. Exp. Eye Res. 1996, 62:555-564.
13. Ganesan K., Raza S.K., Vijayaraghavan R. Chemical warfare agents. J. Pharm. Bioall. Sci. 2010, 2:166-178.
14. Gordon M.K., Enzenauer R.W., Babin M.C. Ocular toxicity of sulfur mustard. Handbook of Toxicology of Chemical Warfare Agents 2009, Elsevier, USA. R.C. Gupta (Ed.).
15. Gordon M.K., Desantis A., Deshmukh M., Lacey C.J., Hahn R.A., Beloni J., Anumolu S.S., Schlager J.J., Gallo M.A., Gerecke D.R., Heindel N.D., Svoboda K.K., Babin M.C., Sinko P.J. Doxycycline hydrogels as a potential therapy for ocular vesicant injury. J. Ocul. Pharmacol. Ther. 2010, 26:407-419.
16. Inturi S., Tewari-Singh N., Gu M., Shrotriya S., Gomez J., Agarwal C., White C.W., Agarwal R. Mechanisms of sulfur mustard analog 2-chloroethyl ethyl sulfide-induced DNA damage in skin epidermal cells and fibroblasts. Free Radic. Biol. Med. 2011, 51:2272-2280.
17. Jain A.K., Tewari-Singh N., Gu M., Inturi S., White C.W., Agarwal R. Sulfur mustard analog, 2-chloroethyl ethyl sulfide-induced skin injury involves DNA damage and induction of inflammatory mediators, in part via oxidative stress, in SKH-1 hairless mouse skin. Toxicol. Lett. 2011, 205:293-301.
18. Jain A.K., Tewari-Singh N., Orlicky D.J., White C.W., Agarwal R. 2-Chloroethyl ethyl sulfide causes microvesication and inflammation-related histopathological changes in male hairless mouse skin. Toxicology 2011, 282:129-138.
19. Javadi M.A., Yazdani S., Sajjadi H., Jadidi K., Karimian F., Einollahi B., Ja'farinasab M.R., Zare M. Chronic and delayed-onset mustard gas keratitis: report of 48 patients and review of literature. Ophthalmology 2005, 112:617-625.
20. Javadi M.A., Yazdani S., Kanavi M.R., Mohammadpour M., Baradaran-Rafiee A., Jafarinasab M.R., Einollahi B., Karimian F., Zare M., Naderi M., Rabei H.M. Long-term outcomes of penetrating keratoplasty in chronic and delayed mustard gas keratitis. Cornea 2007, 26:1074-1078.
21. Javadi M.A., Jafarinasab M.R., Feizi S., Karimian F., Negahban K. Management of mustard gas-induced limbal stem cell deficiency and keratitis. Ophthalmology 2011, 118:1272-1281.
22. Joseph L.B., Gerecke D.R., Heck D.E., Black A.T., Sinko P.J., Cervelli J.A., Casillas R.P., Babin M.C., Laskin D.L., Laskin J.D. Structural changes in the skin of hairless mice following exposure to sulfur mustard correlate with inflammation and DNA damage. Exp. Mol. Pathol. 2011, 91:515-527.
23. Kadar T., Turetz J., Fishbine E., Sahar R., Chapman S., Amir A. Characterization of acute and delayed ocular lesions induced by sulfur mustard in rabbits. Curr. Eye Res. 2001, 22:42-53.
24. Kadar T., Dachir S., Cohen L., Sahar R., Fishbine E., Cohen M., Turetz J., Gutman H., Buch H., Brandeis R., Horwitz V., Solomon A., Amir A. Ocular injuries following sulfur mustard exposure-pathological mechanism and potential therapy. Toxicology 2009, 263:59-69.
25. Kehe K., Szinicz L. Medical aspects of sulphur mustard poisoning. Toxicology 2005, 214:198-209.
26. Kehe K., Raithel K., Kreppel H., Jochum M., Worek F., Thiermann H. Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells. Arch. Toxicol. 2008, 82:461-470.
27. Kehe K., Balszuweit F., Steinritz D., Thiermann H. Molecular toxicology of sulfur mustard-induced cutaneous inflammation and blistering. Toxicology 2009, 263:12-19.
28. Kimura K., Teranishi S., Kawamoto K., Nishida T. Protective effect of dexamethasone against hypoxia-induced disruption of barrier function in human corneal epithelial cells. Exp. Eye Res. 2011, 92:388-393.
29. Kompella U.B., Kadam R.S., Lee V.H. Recent advances in ophthalmic drug delivery. Ther. Deliv. 2010, 1:435-456.
30. Korkmaz A., Yaren H., Topal T., Oter S. Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation. Arch. Toxicol. 2006, 80:662-670.
31. Kristinsson J.K., Fridriksdottir H., Thorisdottir S., Sigurdardottir A.M., Stefansson E., Loftsson T. Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans. Invest. Ophthalmol. Vis. Sci. 1996, 37:1199-1203.
32. Loftsson T., Frithriksdottir H., Stefansson E., Thorisdottir S., Guthmundsson O., Sigthorsson T. Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits. J. Pharm. Pharmacol. 1994, 46:503-504.
33. Matijasevic Z., Precopio M.L., Snyder J.E., Ludlum D.B. Repair of sulfur mustard-induced DNA damage in mammalian cells measured by a host cell reactivation assay. Carcinogenesis 2001, 22:661-664.
34. Milhorn D., Hamilton T., Nelson M., McNutt P. Progression of ocular sulfur mustard injury: development of a model system. Ann. N. Y. Acad. Sci. 2010, 1194:72-80.
35. Missel P., Chastain J., Mitra A., Kompella U., Kansara V., Duvvuri S., Amrite A., Cheruvu N. In vitro transport and partitioning of AL-4940, active metabolite of angiostatic agent anecortave acetate, in ocular tissues of the posterior segment. J. Ocul. Pharmacol. Ther. 2010, 26:137-146.
36. Morad Y., Banin E., Averbukh E., Berenshtein E., Obolensky A., Chevion M. Treatment of ocular tissues exposed to nitrogen mustard: beneficial effect of zinc desferrioxamine combined with steroids. Investig. Ophthalmol. Vis. Sci. 2005, 46:1640-1646.
37. Naderi M., Jadidi K., Falahati F., Alavi S.A. The effect of sulfur mustard and nitrogen mustard on corneal collagen degradation induced by the enzyme collagenase. Cutan. Ocul. Toxicol. 2010, 29:234-240.
38. Noort D., Benschop H.P., Black R.M. Biomonitoring of exposure to chemical warfare agents: a review. Toxicol. Appl. Pharmacol. 2002, 184:116-126.
39. Olajos E.J., Morgan E.W., Renne R.A., Salem H., McVeety B., Johnson R., Phelps R.L. Acute inhalation toxicity of neutralized chemical agent identification sets (CAIS) containing agent in chloroform. J. Appl. Toxicol. 1998, 18:363-371.
40. Pal A., Tewari-Singh N., Gu M., Agarwal C., Huang J., Day B.J., White C.W., Agarwal R. Sulfur mustard analog induces oxidative stress and activates signaling cascades in the skin of SKH-1 hairless mice. Free Radic. Biol. Med. 2009, 47:1640-1651.
41. Pares A., Planas R., Torres M., Caballeria J., Viver J.M., Acero D., Panes J., Rigau J., Santos J., Rodes J. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J. Hepatol. 1998, 28:615-621.
42. Paromov V., Suntres Z., Smith M., Stone W.L. Sulfur mustard toxicity following dermal exposure: role of oxidative stress, and antioxidant therapy. J. Burns Wounds 2007, 7:e7.
43. Petersen A., Carlsson T., Karlsson J.O., Jonhede S., Zetterberg M. Effects of dexamethasone on human lens epithelial cells in culture. Mol. Vis. 2008, 14:1344-1352.
44. Petrali J.P., Dick E.J., Brozetti J.J., Hamilton T.A., Finger A.V. Acute ocular effects of mustard gas: ultrastructural pathology and immunohistopathology of exposed rabbit cornea. J. Appl. Toxicol. 2000, 20(Suppl. 1):S173-S175.
45. Pradhan S.C., Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J. Med. Res. 2006, 124:491-504.
46. Rajamanickam S., Velmurugan B., Kaur M., Singh R.P., Agarwal R. Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin. Cancer Res. 2010, 70:2368-2378.
47. -/- mice: potential of real-time micro-CT in lung cancer chemoprevention studies. Clin. Cancer Res. 2011, 17:753-761.
48. Rebholz B., Kehe K., Ruzicka T., Rupec R.A. Role of NF-kappaB/RelA and MAPK pathways in keratinocytes in response to sulfur mustard. J. Investig. Dermatol. 2008, 128:1626-1632.
49. Richter M.N., Wachtlin J., Bechrakis N.E., Hoffmann F. Keratoplasty after mustard gas injury: clinical outcome and histology. Cornea 2006, 25:467-469.
50. Ruff A.L., Dillman J.F. Signaling molecules in sulfur mustard-induced cutaneous injury. Eplasty 2007, 8:e2.
51. Saladi R.N., Smith E., Persaud A.N. Mustard: a potential agent of chemical warfare and terrorism. Clin. Exp. Dermatol. 2006, 31:1-5.
52. Shakarjian M.P., Heck D.E., Gray J.P., Sinko P.J., Gordon M.K., Casillas R.P., Heindel N.D., Gerecke D.R., Laskin D.L., Laskin J.D. Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure. Toxicol. Sci. 2010, 114:5-19.
53. Sharma M., Vijayaraghavan R., Agrawal O.P. Comparative toxic effect of nitrogen mustards (HN-1, HN-2, and HN-3) and sulfur mustard on hematological and biochemical variables and their protection by DRDE-07 and its analogues. Int. J. Toxicol. 2010, 29:391-401.
54. Singh R.P., Agarwal R. Mechanisms and preclinical efficacy of silibinin in preventing skin cancer. Eur. J. Cancer 2005, 41:1969-1979.
55. Singh R.P., Agarwal R. Mechanisms of action of novel agents for prostate cancer chemoprevention. Endocr. Relat. Cancer 2006, 13:751-778.
56. Singh R.P., Agarwal R. Cosmeceuticals and silibinin. Clin. Dermatol. 2009, 27:479-484.
57. Smith V.A., Cook S.D. Doxycycline-a role in ocular surface repair. Br. J. Ophthalmol. 2004, 88:619-625.
58. Smith K.J., Skelton H. Chemical warfare agents: their past and continuing threat and evolving therapies. Part I of II. Skinmed 2003, 2:215-221.
59. Smith K.J., Smith W.J., Hamilton T., Skelton H.G., Graham J.S., Okerberg C., Moeller R., Hackley B.E. Histopathologic and immunohistochemical features in human skin after exposure to nitrogen and sulfur mustard. Am. J. Dermatopathol. 1998, 20:22-28.
60. Solomon A., Rosenblatt M., Li D., Monroy D., Ji Z., Lokeshwar B.L., Pflugfelder S.C. Doxycycline inhibition of interleukin-1 in the corneal epithelium. Am. J. Ophthalmol. 2000, 130:688.
61. Tewari-Singh N., Rana S., Gu M., Pal A., Orlicky D.J., White C.W., Agarwal R. Inflammatory biomarkers of sulfur mustard analog 2-chloroethyl ethyl sulfide-induced skin injury in SKH-1 hairless mice. Toxicol. Sci. 2009, 108:194-206.
62. Tewari-Singh N., Gu M., Agarwal C., White C.W., Agarwal R. Biological and molecular mechanisms of sulfur mustard analogue-induced toxicity in JB6 and HaCaT cells: possible role of ataxia telangiectasia-mutated/ataxia telangiectasia-Rad3-related cell cycle checkpoint pathway. Chem. Res. Toxicol. 2010, 23:1034-1044.
63. Tewari-Singh N., Jain A.K., Inturi S., White C.W., Agarwal R. Therapeutic efficacy of silibinin, a natural flavanone, in sulfur mustard analog-induced skin toxicity. 49th Annual Meeting of the Society of Toxicology 2010, 108. Society of Toxicology, Salt Lake City, Utah.
64. Tewari-Singh N., Agarwal C., Huang J., Day B.J., White C.W., Agarwal R. Efficacy of glutathione in ameliorating sulfur mustard analog-induced toxicity in cultured skin epidermal cells and in SKH-1 mouse skin in vivo. J. Pharmacol. Exp. Ther. 2011, 336:450-459.
65. Velmurugan B., Gangar S.C., Kaur M., Tyagi A., Deep G., Agarwal R. Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules. Pharm. Res. 2010, 27:2085-2097.
66. Wang G.Q., Xia Z.F. Tissue injury by hot fluid containing nitrogen mustard. Burns 2007, 33:923-926.
67. Yeh Y.C., Lai H.C., Ting C.T., Lee W.L., Wang L.C., Wang K.Y., Liu T.J. Protection by doxycycline against doxorubicin-induced oxidative stress and apoptosis in mouse testes. Biochem. Pharmacol. 2007, 74:969-980.